Clinical trial reportClinical pharmacology in drug developmentPublished
A Phase 1, Open-Label, Single-Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Clinical pharmacology in drug development
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Liver Diseases; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Protein Kinase Inhibitors; Administration, Oral; Severity of Illness Index; Area Under Curve; Adult; Aged; Middle Aged
- PubMed ID
- 42057702
- PubMed Central ID
- PMC13129628
- Open access
- Yes, open
- Added to directory
- Source checked